Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Cresilon announced its revolutionary hemostatic gel TRAUMAGEL(R) has received an Innovative Technology contract from Vizient(R) the nation's largest provider-driven healthcare performance improvement ...

The last time a college student founded a healthcare startup promising to do something revolutionary with blood, it ended up being quite messy. Hopefully things go better for Cresilon. The ...

A Brooklyn-based biotech company has applied for FDA approval for the human use of a plant-based gel technology that the company says rapidly controls bleeding and seals wounds in less than 10 seconds ...

INDUSTRY CITY AND SUNSET PARK — Brooklyn-based biotechnology company Cresilon Inc. uncovered a hemostatic gel technology that will make traumatic brain injuries (TBI) significantly less devastating.

NEW YORK (PIX11) — A Brooklyn-based company now has the green light to sell a potentially life-saving gel that stops bleeding on contact. Traumagel has been cleared by the FDA for use by medical ...

NEW YORK, April 8, 2021 /PRNewswire/ — Cresilon, Inc., the Brooklyn-based biotechnology company, announced today the successful close of its Series A-3 financing, totaling $38.5 million. This ...

Please provide your email address to receive an email when new articles are posted on . Syringe delivery of Traumagel allows first responders precise application into hard-to-reach wound areas. When ...

NEW YORK, July 9, 2024 /PRNewswire/ -- Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced the successful completion ...

Pune, Maharashtra, December 17 2020 (Wiredrelease) Market.Biz –:Businesses must navigate the financial and operational challenges of coronavirus while rapidly addressing the needs of their people, ...